TD Cowen raised the firm’s price target on Alpha Teknova (TKNO) to $10 from $8 and keeps a Buy rating on the shares. The firm provided a Q4 preview for the Life Science Tools sector where positive signs related to R&D spend, elongated sales cycles, and inventory de-stocking are likely to fight for attention with concerns over NIH, China, and policy uncertainty.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Questions or Comments about the article? Write to editor@tipranks.com